<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-142989" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Charles Bonnet Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rojas</surname>
            <given-names>Luis C.</given-names>
          </name>
          <aff>McLaren Macomb - Michigan State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gurnani</surname>
            <given-names>Bharat</given-names>
          </name>
          <aff>Gomabai Netralaya and Research Centre</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Luis Rojas declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bharat Gurnani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-142989.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Charles Bonnet syndrome (CBS) is a phenomenon characterized by complex visual hallucinations in visually challenged patients but otherwise psychologically normal. The phenomenon was first described in 1760 by Swiss philosopher Charles Bonnet who observed this phenomenon in his grandfather, who was visually impaired due to cataracts. In this phenomenon, the hallucinations have been described as formed, vivid, of realistic objects or people, and they tend to recur. In CBS, the patient is aware that the image is not real and may see these images as disturbing. However, hallucinations can also fit in the visual phenomenon and may be indiscernible from real objects. Hallucinations are described as the perception of unrealistic images, sounds, or smells in the absence of any external stimulus. Hallucinations in older people are usually markers of underlying neurological disorders like Alzheimer disease, parkinsonism, delirium, sensory deprivation, insomnia, or psychosis. The other type of hallucination is release hallucination which usually originates from the external world but is experienced when there is an inadequate stimulus to the sensory system. The hallucinations in CBS are visual and complex but are not disturbing. CBS can also be a marker of dementia in elderly patients. CBS can manifest when there is a lesion at any level of the visual system, and typically patients manifest with a loss of central visual acuity. CBS is also associated with ARMD with a secondary decline in visual acuity. This activity deals with the etiology, epidemiology, and pathophysiology of CBS and highlights the role of the interprofessional team in the investigation and treatment of CBS.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of Charles Bonnet syndrome.</p></list-item><list-item><p>Review the epidemiology of Charles Bonnet syndrome.</p></list-item><list-item><p>Summarize the clinical findings of Charles Bonnet syndrome.</p></list-item><list-item><p>Explain the treatment of Charles Bonnet syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=142989&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=142989">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-142989.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Charles Bonnet syndrome (CBS) is a medical condition in which complex visual hallucinations occur concurrently with visual changes, specifically visual field loss or visual acuity loss.<xref ref-type="bibr" rid="article-142989.r1">[1]</xref> As the disease occurs in those with visual impairment or vision loss, the pathways leading to CBS include any involvement in the visual pathway, including the optic nerve, brain, or eyes.<xref ref-type="bibr" rid="article-142989.r2">[2]</xref></p>
        <p>Due to the nature of hallucinations and the most common etiologies, CBS often goes unrecognized and misdiagnosed with early dementia or psychosis. The patient is usually unaware of the unreality of visual experiences, which are typically normal to the brain but sometimes may result in distress. The patient has minimal or no control over the hallucinations, which are clear, well-defined, organized images.<xref ref-type="bibr" rid="article-142989.r3">[3]</xref></p>
        <p>The Swiss scientist Charles Bonnet initially described CBS in 1760, who first noticed this phenomenon of visual hallucination in his 90-year-old grandfather, who was suffering from cataracts.<xref ref-type="bibr" rid="article-142989.r4">[4]</xref> The grandfather underwent cataract surgery and the initial vision improved, but later the visual acuity deteriorated, and he noticed visual hallucinations.<xref ref-type="bibr" rid="article-142989.r5">[5]</xref> The hallucinations were unreal, and the grandfather didn't suffer from psychiatric disorders. This is a kind of release phenomenon due to the deafferentation of the cerebral cortex's visual association areas, giving rise to phantom vision.<xref ref-type="bibr" rid="article-142989.r6">[6]</xref></p>
        <p>Cognitive malfunction, social isolation, and sensory deprivation have been liked as the primary etiologies of CBS. CBS is often missed until the elderly age group due to fear of being labeled as mentally retarded and phobia of admitting hallucinations.<xref ref-type="bibr" rid="article-142989.r7">[7]</xref></p>
        <p>Patients who notice the unreal nature of their hallucinations may be depressed by the fear of imminent insanity. A detailed and systemic history is essential to rule out the existence of hallucinations. The hallucinations may improve spontaneously, or on improvement with vision, or dealing with social isolation.<xref ref-type="bibr" rid="article-142989.r8">[8]</xref></p>
        <p>Anticonvulsants have been shown to improve and abort hallucination, but there is no drug of choice for CBS. The awareness of the Ophthalmologist and the physician are the critical components of management.<xref ref-type="bibr" rid="article-142989.r9">[9]</xref></p>
        <p>
<bold>Pathogenetic Theories of Charles Bonnet Syndrome</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sensory deprivation&#x02014;phantom vision</p>
          </list-item>
          <list-item>
            <p>Dreams and hallucinations</p>
          </list-item>
          <list-item>
            <p>Theory of perceptual release</p>
          </list-item>
          <list-item>
            <p>The neuromatrix theory</p>
          </list-item>
          <list-item>
            <p>Irritative and release hallucinations</p>
          </list-item>
          <list-item>
            <p>Social isolation</p>
          </list-item>
          <list-item>
            <p>Senescence</p>
          </list-item>
          <list-item>
            <p>Psychological factors</p>
          </list-item>
          <list-item>
            <p>Cerebral perfusion theory<xref ref-type="bibr" rid="article-142989.r10">[10]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-142989.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Except for congenital blindness, CBS can originate from any factor affecting the visual pathway, extending from the visual cortex down to the eyes.<xref ref-type="bibr" rid="article-142989.r11">[11]</xref></p>
        <p>Common etiologies include</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic retinopathy</p>
          </list-item>
          <list-item>
            <p>Age-related macular degeneration</p>
          </list-item>
          <list-item>
            <p>Cerebral infarctions</p>
          </list-item>
          <list-item>
            <p>Glaucoma</p>
          </list-item>
          <list-item>
            <p>Macular degeneration</p>
          </list-item>
          <list-item>
            <p>Cataract</p>
          </list-item>
          <list-item>
            <p>High myopia</p>
          </list-item>
          <list-item>
            <p>Retinitis Pigmentosa</p>
          </list-item>
          <list-item>
            <p>Optic Neuritis</p>
          </list-item>
          <list-item>
            <p>Retinal vein occlusion</p>
          </list-item>
          <list-item>
            <p>Central retinal arterial occlusion</p>
          </list-item>
          <list-item>
            <p>Occipital stroke</p>
          </list-item>
          <list-item>
            <p>Temporal arteritis</p>
          </list-item>
        </list>
        <p>The proposed theory for CBS is the phantom limb pain theory. Phantom limb pain theory explains a feeling of pain even when the limb has been removed. The patient feels pain even though the limb has been removed. Similarly, patients with CBS may have visual sensations despite being unable to see them.<xref ref-type="bibr" rid="article-142989.r12">[12]</xref></p>
      </sec>
      <sec id="article-142989.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence and prevalence of CBS are still under investigation and require further research. However, various studies and surveys indicate that the condition is not as uncommon as one might think. CBS prevalence has been found to differ widely depending on different sample sizes, with estimates ranging from 1% to nearly 10%.<xref ref-type="bibr" rid="article-142989.r13">[13]</xref>&#x000a0;</p>
        <p>One large study aimed at investigating CBS found the overall prevalence to be 0.5% (5/1000), with 0.8% (1/120) of their sample being in those with low visual acuity, 0.6% (2/346) being in the elderly, and 0.8% (1/120) being in both the elderly and those with low visual acuity.<xref ref-type="bibr" rid="article-142989.r13">[13]</xref></p>
        <p>Further highlighting the predominance in those with a higher degree of visual impairment or even more in those with complete vision loss, a study comparing visual hallucinations in people with macular disease versus people with glaucoma involved in a visual rehabilitation found the prevalence of CBS to be 39% and 20% respectively.<xref ref-type="bibr" rid="article-142989.r14">[14]</xref></p>
        <p>Regarding age, CBS can affect all ages; however, it tends to be more prevalent in older individuals. Data on CBS shows the mean age of the condition to be 70 to 85 years old, the expected range where pathological processes leading to visual impairment or vision loss naturally occur.<xref ref-type="bibr" rid="article-142989.r11">[11]</xref><xref ref-type="bibr" rid="article-142989.r15">[15]</xref><xref ref-type="bibr" rid="article-142989.r16">[16]</xref></p>
        <p>However, literature has suggested that CBS is vastly under-reported, mainly due to patients fearing being diagnosed with a psychiatric illness.<xref ref-type="bibr" rid="article-142989.r17">[17]</xref><xref ref-type="bibr" rid="article-142989.r18">[18]</xref>&#x000a0;For instance, one study found that a significant number of patients are unaware of the disease, with only 12% of patients in a retinal clinic knowing of CBS.<xref ref-type="bibr" rid="article-142989.r19">[19]</xref> In contrast, another study found that visual hallucinations were reported in only 11 to 15% of older individuals with impaired vision.<xref ref-type="bibr" rid="article-142989.r20">[20]</xref></p>
        <p>CBS is more common in elder patients. Previous reports have revealed the mean age of incidence ranging from 74&#x000a0;to 84 years. CBS has also been reported in children having a high incidence of rapid visual loss. The incidence of profound visual loss is also reported more commonly in the elderly. De Morsier noted a male preponderance; some studies showed a female preponderance, while some showed no sex bias.<xref ref-type="bibr" rid="article-142989.r21">[21]</xref></p>
      </sec>
      <sec id="article-142989.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of CBS first starts with any factor that leads to loss of vision. These factors which can affect any part of the visual pathway commonly include cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration, and cerebral infarction affecting the visual cortex.<xref ref-type="bibr" rid="article-142989.r17">[17]</xref><xref ref-type="bibr" rid="article-142989.r11">[11]</xref><xref ref-type="bibr" rid="article-142989.r15">[15]</xref>&#x000a0;</p>
        <p>The current and most commonly accepted theory for the visual hallucinations seen in CBS is that visual sensory deafferentation results in disinhibitions of cortical regions affecting vision.<xref ref-type="bibr" rid="article-142989.r14">[14]</xref><xref ref-type="bibr" rid="article-142989.r22">[22]</xref>&#x000a0;</p>
        <p>Ultimately, this disinhibition leads to spontaneous firing of these vision-associated regions, resulting in hallucinations. Studies supporting this theory have shown through neuroimaging that visual cortical regions, such as the ventral occipital lobe, spontaneously fire during hallucinations in patients who met diagnostic criteria.<xref ref-type="bibr" rid="article-142989.r23">[23]</xref>&#x000a0;</p>
        <p>Furthermore, neuroimaging also revealed that the hallucinations correlate with the functions of the involved firing cortical region. Due to the process by which the hallucinations are understood, CBS is not seen in congenital blindness.<xref ref-type="bibr" rid="article-142989.r24">[24]</xref></p>
      </sec>
      <sec id="article-142989.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with CBS will report a history of "release hallucinations," which is often synonymous with CBS, describing visual hallucinations that occur in individuals with vision loss related to the brain, optic nerve, or eye involvement.<xref ref-type="bibr" rid="article-142989.r25">[25]</xref><xref ref-type="bibr" rid="article-142989.r16">[16]</xref><xref ref-type="bibr" rid="article-142989.r26">[26]</xref><xref ref-type="bibr" rid="article-142989.r27">[27]</xref>&#x000a0;</p>
        <p>Patients with chronic slow-progressing ocular disease typically report hallucinations at least one year after severe visual impairment or complete vision loss.<xref ref-type="bibr" rid="article-142989.r17">[17]</xref><xref ref-type="bibr" rid="article-142989.r28">[28]</xref><xref ref-type="bibr" rid="article-142989.r15">[15]</xref>&#x000a0;In comparison, patients with acute vision loss secondary to the optic nerve or brain damage will typically report hallucinations within hours or days of inciting events; however, hallucinations can still be reported within months as well.<xref ref-type="bibr" rid="article-142989.r29">[29]</xref><xref ref-type="bibr" rid="article-142989.r30">[30]</xref><xref ref-type="bibr" rid="article-142989.r31">[31]</xref><xref ref-type="bibr" rid="article-142989.r32">[32]</xref>&#x000a0;</p>
        <p>The visual hallucinations can vary from described events such as light flashes, shapes, or lines to complex events, including formed images and scenes.<xref ref-type="bibr" rid="article-142989.r33">[33]</xref><xref ref-type="bibr" rid="article-142989.r34">[34]</xref>&#x000a0;Furthermore, it has been reported that in patients with CBS in which vision loss was attributed to neurologic or retinal causes, simple hallucinations were more prevalent than complex ones at 90% and 37%, respectively.<xref ref-type="bibr" rid="article-142989.r31">[31]</xref>&#x000a0;</p>
        <p>Hallucinations are typically colored and range in the visual field from being animated, static, or moving en block.&#x000a0;Patients will also report that hallucinations are more prevalent with eyes open than closed. Patients with CBS will also often report distress from their hallucinations, even though they often recognize them as unreal and disconnected from themselves.&#x000a0;Lastly, in obtaining a patient's history, it is essential to note that CBS is not associated with sensory or auditory hallucinations.<xref ref-type="bibr" rid="article-142989.r34">[34]</xref>&#x000a0;</p>
        <p>Moreover, the hallucinations observed in CBS can be typically simple or complex, even though a full complex spectrum of hallucinations can exist.<xref ref-type="bibr" rid="article-142989.r18">[18]</xref> Simple hallucinations can be elementary or formed and composed of photopsia, a grid-like pattern, simple pattern shapes, or branching patterns.<xref ref-type="bibr" rid="article-142989.r28">[28]</xref></p>
        <p>Complex visual hallucinations are composed of lucid and complicated images of people, faces, animals, plants, flowers, trees, vehicles, and images of objects.<xref ref-type="bibr" rid="article-142989.r25">[25]</xref> Outside of the history of visual hallucinations, physical examination involves assessing any processes of vision loss.<xref ref-type="bibr" rid="article-142989.r35">[35]</xref></p>
        <p>Ophthalmologic examination, identifying features like glaucoma, macular degeneration, cataracts, and retinal or optic nerve damage, can also be critical components of the physical exam as CBS requires visual impairment to be concurrent with reported visual hallucinations.<xref ref-type="bibr" rid="article-142989.r15">[15]</xref> Neurological deficits seen in cerebrovascular accidents can also be seen in presentation as damage to the cortex involving the visual pathway is another crucial component of CBS.<xref ref-type="bibr" rid="article-142989.r11">[11]</xref></p>
        <p>In a study from London, 38% of the 492 subjects&#x000a0;reported visual hallucinations as frightening, horrifying, and startling during the onset. With time the emotional inputs to hallucinations reduced to 8%.<xref ref-type="bibr" rid="article-142989.r17">[17]</xref></p>
        <p>In 60% of patients, visual hallucinations didn't affect their lives, 33% said it had a negative impact, and 7% felt it had a good effect on their lives.<xref ref-type="bibr" rid="article-142989.r11">[11]</xref> However, the definition of CBS mentions complex visual hallucinations. In clinical practice, the patients frequently present with simple visual hallucinations.<xref ref-type="bibr" rid="article-142989.r18">[18]</xref></p>
        <p>The patients manifest with some level of visual impairment; the visual hallucinations are better with more clarity than the residual vision. These visual hallucinations are vivid and are not under voluntary control. The hallucinations are exclusively visual and do not involve any other sensory modality. CBS patients manifest hallucinations when awake, alert and conscious. The patients have no dementia, and their mental function is preserved. The mental intellect, awareness, reasoning, judgment, and applications of knowledge are intact.<xref ref-type="bibr" rid="article-142989.r34">[34]</xref></p>
      </sec>
      <sec id="article-142989.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The first step in evaluating for CBS is assessing for neurocognitive disorders, neurological deficits, and neurocognitive impairment through a comprehensive neurological examination. Workup can include brain imaging, electroencephalography (EEG), laboratory exams, and genetic testing depending on suspected neurological conditions.&#x000a0;</p>
        <p>A medication reconciliation assessment for hallucinations induced by medications should also be completed. Some common non-psychotropic medicines that have been found to cause hallucinations include beta-blockers, glucocorticoids, angiotensin-converting enzyme inhibitors, cimetidine, ranitidine, sildenafil, digoxin, carbapenems, penicillins, macrolides, cephalosporins, linezolid, and doxycycline.<xref ref-type="bibr" rid="article-142989.r36">[36]</xref><xref ref-type="bibr" rid="article-142989.r37">[37]</xref><xref ref-type="bibr" rid="article-142989.r38">[38]</xref>&#x000a0;Even more common than the medications just mentioned include those over the counter, including ephedrine and synthetic cannabinoids.</p>
        <p>Lastly, psychotropic medications and drugs of abuse must also be ruled out as the cause of hallucinations.<xref ref-type="bibr" rid="article-142989.r39">[39]</xref> Upon ruling out hallucinations secondary to an underlying neurological condition or medication, the next step is confirming the presence of vision impairment or loss through a thorough ophthalmologic evaluation with visual field testing.<xref ref-type="bibr" rid="article-142989.r40">[40]</xref></p>
        <p>Brain imaging may also be used to assess for impaired or loss of vision in individuals whose eye exam is unremarkable.<xref ref-type="bibr" rid="article-142989.r41">[41]</xref> In summary, a diagnosis of CBS can be made in individuals having only visual hallucinations in the absence of neurologic abnormalities while in the presence of known vision impairment or loss.<xref ref-type="bibr" rid="article-142989.r42">[42]</xref></p>
      </sec>
      <sec id="article-142989.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of CBS can vary depending on the severity of symptoms. In mild symptoms, reassurance may be all that is needed. However, in more severe symptoms, treatment includes behavioral techniques and medications to suppress hallucinations. Studied techniques include blinking during hallucination or rapid eye movement from one object to another away from the perceived hallucination field of vision.<xref ref-type="bibr" rid="article-142989.r22">[22]</xref>&#x000a0;The mainstay of management is physician awareness and compassion.<xref ref-type="bibr" rid="article-142989.r35">[35]</xref><xref ref-type="bibr" rid="article-142989.r43">[43]</xref></p>
        <p>
<bold>Pharmacotherapy</bold>
</p>
        <p>Medications are often reserved for severe diseases, including those with disturbing or continuous hallucinations. Antipsychotics have been found to have mixed efficacy; however, atypical antipsychotics such as low doses of quetiapine or olanzapine are preferred due to safer side effect profiles, especially in the elderly CBS tends to affect.<xref ref-type="bibr" rid="article-142989.r44">[44]</xref><xref ref-type="bibr" rid="article-142989.r33">[33]</xref>&#x000a0;</p>
        <p>Other medications with good efficacy and minimal side effects include cholinesterase inhibitors such as donepezil. Beneficial medications anecdotally include antiepileptics such as valproate, carbamazepine, gabapentin, and clonazepam. Lastly, some promising medications that are effective in small case series include antidepressants such as venlafaxine and escitalopram, as well as prokinetic agents like cisapride.<xref ref-type="bibr" rid="article-142989.r45">[45]</xref><xref ref-type="bibr" rid="article-142989.r46">[46]</xref></p>
        <p>
<bold>Psychological Therapy</bold>
</p>
        <p>Various techniques such as hypnosis, relaxation training, distraction, cognitive remodeling, and psychological therapy for the phantom phenomenon have been advocated to minimize visual hallucinations' unpleasant and troublesome effects.<xref ref-type="bibr" rid="article-142989.r47">[47]</xref></p>
        <p>
<bold>Reassurance and Counselling </bold>
</p>
        <p>CBS patients may experience anxiety and are usually unaware of the condition. Many patients may show disappointment and unsympathetic reactions to meeting the healthcare professional regarding their hallucinations.<xref ref-type="bibr" rid="article-142989.r10">[10]</xref> Reassurance is necessary as most patients are comforted when told that it's not a psychiatric phenomenon but is named CBS. The patients are also reassured that vision loss is benign and not harmful and there is no underlying mental illness.<xref ref-type="bibr" rid="article-142989.r48">[48]</xref></p>
        <p>Patients with intact cognition need no further intervention, but patients having dementia may be difficult to reassure because of a lack of insight and vision loss of distressing nature. Reassurance and counseling are the mainstays of treatment.<xref ref-type="bibr" rid="article-142989.r49">[49]</xref></p>
        <p>
<bold>Optimizing Visual Function</bold>
</p>
        <p>This beneficial impact on hallucination may be the best treatment, although visual deficit correction may not always be possible, especially in elderly patients. The spectacle and visual aid prescription are necessary for optical correction, and cataract surgery may be necessary for visual correction.<xref ref-type="bibr" rid="article-142989.r2">[2]</xref></p>
      </sec>
      <sec id="article-142989.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Essential considerations for differential diagnosis pertain to etiologies involving visual hallucinations. These include</p>
        <list list-type="bullet">
          <list-item>
            <p>Narcolepsy</p>
          </list-item>
          <list-item>
            <p>Peduncular hallucinosis</p>
          </list-item>
          <list-item>
            <p>Levodopa-induced hallucinations</p>
          </list-item>
          <list-item>
            <p>Hypnagogic hallucinations</p>
          </list-item>
          <list-item>
            <p>Migraine coma</p>
          </list-item>
          <list-item>
            <p>Schizophrenia</p>
          </list-item>
          <list-item>
            <p>Epileptic seizures</p>
          </list-item>
          <list-item>
            <p>Dementia</p>
          </list-item>
          <list-item>
            <p>Migraine aura</p>
          </list-item>
          <list-item>
            <p>Neurodegenerative - Parkinson, Alzheimer, and Lewy body dementia</p>
          </list-item>
          <list-item>
            <p>Metabolic encephalopathy - drugs, alcohol withdrawal, or delirium</p>
          </list-item>
        </list>
        <p>CBS is differentiated from all these conditions simultaneous presence of visual deficits and the absence of neurological deficits. Furthermore, CBS is differentiated by the lack of auditory or sensory-associated hallucinations, which can be seen in many&#x000a0;of the above differentials.</p>
      </sec>
      <sec id="article-142989.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of CBS largely depends on the underlying cause of vision impairment or loss, with multiple symptoms associated with chronic ocular disease lasting multiple years.<xref ref-type="bibr" rid="article-142989.r14">[14]</xref>&#x000a0;</p>
        <p>One study highlighting this association found that 75% of patients with macular disease reported hallucinations for at least five years or more. In contrast, the prognosis is better in conditions where visual impairment can be quickly corrected, such as cataracts.<xref ref-type="bibr" rid="article-142989.r50">[50]</xref><xref ref-type="bibr" rid="article-142989.r45">[45]</xref>&#x000a0;</p>
        <p>The prognosis of CBS can also be variable, with remitting visual hallucinations in those with slow progressing or stable vision impairment.<xref ref-type="bibr" rid="article-142989.r14">[14]</xref> The individuals usually affected in this variable fashion are those affected by CVAs, with many having hallucinations lasting from a few weeks to a few days.<xref ref-type="bibr" rid="article-142989.r22">[22]</xref></p>
        <p>Lastly, outside of the visual hallucinations associated with CBS, the condition has also been associated with the development of dementia. One study showing this association found that 26% of individuals with CBS developed dementia around an average of 33 months.<xref ref-type="bibr" rid="article-142989.r51">[51]</xref></p>
      </sec>
      <sec id="article-142989.s11" sec-type="Complications">
        <title>Complications</title>
        <p>CBS is described and understood as a transient condition not associated with significant adverse consequences or complications outside of worsening hallucinations. CBS complications mainly pertain to the psychological effects of the illusions experienced by patients.</p>
        <p>Patients often fail to inform any medical staff or family and ultimately start believing they are becoming mentally ill.&#x000a0;Further illustrating this phenomenon, a study in 2014 showed that approximately 32% of those with CBS are emotionally distressed from their hallucination.<xref ref-type="bibr" rid="article-142989.r14">[14]</xref></p>
      </sec>
      <sec id="article-142989.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Any patient presenting with hallucinations and vision loss should undergo a detailed evaluation by an ophthalmologist and a neurologist.<xref ref-type="bibr" rid="article-142989.r1">[1]</xref> There should be a detailed assessment of neuropsychological status to pinpoint underlying pathology. It is highly imperative to rule out other causes of visual hallucinations.</p>
        <p>The psychiatrist and the rehabilitation therapist also play an essential role in these patients. All patients should undergo a mini-mental state examination by a neurologist, and if needed, a psychiatric evaluation should be done if there is cognitive decline.<xref ref-type="bibr" rid="article-142989.r52">[52]</xref></p>
      </sec>
      <sec id="article-142989.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence and patient education on CBS mainly relate to inquiring about visual hallucinations in those experiencing vision loss. Additionally, providing education on the condition from a primary prevention standpoint is also vital, given that many patients fail to report hallucinations due to the fear of being seen as mentally ill.<xref ref-type="bibr" rid="article-142989.r52">[52]</xref>&#x000a0;</p>
        <p>Studies have shown that education on CBS before the onset of hallucinations reduces negative symptoms such as fear or stress-related hallucinations impacting daily activities.&#x000a0;For those who report hallucinations and meet diagnostic criteria, it is crucial to provide reassurance that CBS is primarily a transient condition unrelated to dementia or being mentally ill.<xref ref-type="bibr" rid="article-142989.r14">[14]</xref></p>
      </sec>
      <sec id="article-142989.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>A detailed literature review reveals a lot of controversies and changing consensus over the inclusion and exclusion criteria for CBS.<xref ref-type="bibr" rid="article-142989.r53">[53]</xref> Despite this disagreement, the management protocol remains the same. Despite the well-defined and strict diagnostic criteria, we usually overlook the clinical significance of CBS, as visual hallucinations can occur in patients with visual impairment. CBS patients are typically elderly and are usually depressed by their visual acuity, the nature of which is not understood by these patients. If attention is not pain, CBS can be misdiagnosed and inappropriate treatment.<xref ref-type="bibr" rid="article-142989.r1">[1]</xref></p>
        <p>Another essential thing to be kept in mind is that the majority of information on CBS is detailed in psychiatric literature than ophthalmic literature. If the patients present with hallucinations, they are labeled as mentally unstable and referred to a psychiatrist.<xref ref-type="bibr" rid="article-142989.r54">[54]</xref></p>
        <p>To an ophthalmologist, these patients present with visual impairment, as most suffer from defective vision. Even the first described patients, Lullin and Bonnet, presented with ocular pathology, and the ophthalmologists rarely encountered these patients with visual hallucinations.<xref ref-type="bibr" rid="article-142989.r2">[2]</xref></p>
        <p>CB-type visual hallucinations without a visual loss should be labeled as separate entities. Cognitive decline is another contributory factor but is rarely the primary etiological factor. The most widely accepted definition of CBS is sensory deprivation-deafferentation- of the cerebral cortex and release phenomenon of hallucinations. CBS may mimic Alzheimer and Parkinsonism as cognition is impaired in all these conditions.<xref ref-type="bibr" rid="article-142989.r6">[6]</xref></p>
      </sec>
      <sec id="article-142989.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Enhancement of healthcare team outcomes on CBS primarily revolves around primary care working with interdisciplinary fields such as ophthalmology, neurology, and psychiatry. When patients can be appropriately assessed and meet diagnostic criteria for CBS, providing education and reassurance on the condition is often all that is needed to reduce anxiety, concerns, and other adverse outcomes related to CBS.<xref ref-type="bibr" rid="article-142989.r18">[18]</xref></p>
        <p>Interprofessional care coordination is also necessary for managing CBS. Pharmacists can provide information regarding potential medication causes for the patient's presentation. Nurses can assist with examinations, perform patient counseling, and serve as care coordinators among various practitioners.</p>
        <p>All interprofessional team members are tasked with providing accurate records of their interactions and interventions with the patient. They need to be empowered to contact other team members if they have any concerns about the patient's condition or note any status changes. This interprofessional model will provide the best opportunity for a positive outcome. [Level 5]</p>
      </sec>
      <sec id="article-142989.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=142989&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=142989">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/charles-bonnet-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=142989">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/142989/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=142989">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-142989.s17">
        <fig id="article-142989.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Digital image of a patient depicting cataractous lens in a patient with Charles Bonnet Syndrome Contributed by Bharat Gurnani, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Cataract__in__a__Patient__with__CBS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-142989.s18">
        <title>References</title>
        <ref id="article-142989.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Del Castillo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations: charles bonnet syndrome.</article-title>
            <source>West J Emerg Med</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>544</fpage>
            <page-range>544-7</page-range>
            <pub-id pub-id-type="pmid">23357937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome.</article-title>
            <source>Optom Vis Sci</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>93</volume>
            <issue>12</issue>
            <fpage>1466</fpage>
            <page-range>1466-1478</page-range>
            <pub-id pub-id-type="pmid">27529611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Haj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roche</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jardri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kapogiannis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gallouj</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Antoine</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.</article-title>
            <source>Neurosci Biobehav Rev</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>83</volume>
            <fpage>713</fpage>
            <page-range>713-720</page-range>
            <pub-id pub-id-type="pmid">28235545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ferencz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cases: Charles Bonnet syndrome: visual loss and hallucinations.</article-title>
            <source>CMAJ</source>
            <year>2009</year>
            <month>Aug</month>
            <day>04</day>
            <volume>181</volume>
            <issue>3-4</issue>
            <fpage>175</fpage>
            <page-range>175-6</page-range>
            <pub-id pub-id-type="pmid">19652169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozcan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yucel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ates</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Visual Hallucinations in an Old Patient after Cataract Surgery and Treatment.</article-title>
            <source>Eurasian J Med</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-4</page-range>
            <pub-id pub-id-type="pmid">27026767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teeple</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Caplan</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations: differential diagnosis and treatment.</article-title>
            <source>Prim Care Companion J Clin Psychiatry</source>
            <year>2009</year>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-32</page-range>
            <pub-id pub-id-type="pmid">19333408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donovan</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Blazer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Social Isolation and Loneliness in Older Adults: Review and Commentary of a National Academies Report.</article-title>
            <source>Am J Geriatr Psychiatry</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1233</fpage>
            <page-range>1233-1244</page-range>
            <pub-id pub-id-type="pmid">32919873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husain</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Chaudhry</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Blakemore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shakoor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kiran</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jafri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Memon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panagioti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan.</article-title>
            <source>SAGE Open Med</source>
            <year>2021</year>
            <volume>9</volume>
            <fpage>20503121211032813</fpage>
            <pub-id pub-id-type="pmid">34659761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cinar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karsidag</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Eye-related visual hallucinations: consider 'Charles Bonnet syndrome'.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2011</year>
            <season>May-Jun</season>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-30</page-range>
            <pub-id pub-id-type="pmid">21586846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ditzel-Finn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Enoch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moosajee</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An overview of psychological and social factors in Charles Bonnet syndrome.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2021</year>
            <season>Jan-Dec</season>
            <volume>13</volume>
            <fpage>25158414211034715</fpage>
            <pub-id pub-id-type="pmid">34377938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teunisse</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cruysberg</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hoefnagels</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Verbeek</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Zitman</surname>
                <given-names>FG</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome.</article-title>
            <source>Lancet</source>
            <year>1996</year>
            <month>Mar</month>
            <day>23</day>
            <volume>347</volume>
            <issue>9004</issue>
            <fpage>794</fpage>
            <page-range>794-7</page-range>
            <pub-id pub-id-type="pmid">8622335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subedi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Grossberg</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Phantom limb pain: mechanisms and treatment approaches.</article-title>
            <source>Pain Res Treat</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>864605</fpage>
            <pub-id pub-id-type="pmid">22110933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiraishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Terao</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ibi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tawara</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The rarity of Charles Bonnet syndrome.</article-title>
            <source>J Psychiatr Res</source>
            <year>2004</year>
            <season>Mar-Apr</season>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-13</page-range>
            <pub-id pub-id-type="pmid">14757336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cox</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>ffytche</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Negative outcome Charles Bonnet syndrome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>9</issue>
            <fpage>1236</fpage>
            <page-range>1236-9</page-range>
            <pub-id pub-id-type="pmid">24825847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menon</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dutton</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2003</year>
            <season>Jan-Feb</season>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-72</page-range>
            <pub-id pub-id-type="pmid">12559327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schultz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Melzack</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The Charles Bonnet syndrome: 'phantom visual images'.</article-title>
            <source>Perception</source>
            <year>1991</year>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>809</fpage>
            <page-range>809-25</page-range>
            <pub-id pub-id-type="pmid">1816537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scott</surname>
                <given-names>IU</given-names>
              </name>
              <name>
                <surname>Schein</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Feuer</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Folstein</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations in patients with retinal disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2001</year>
            <month>May</month>
            <volume>131</volume>
            <issue>5</issue>
            <fpage>590</fpage>
            <page-range>590-8</page-range>
            <pub-id pub-id-type="pmid">11336933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nesher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nesher</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Assia</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Charles Bonnet syndrome in glaucoma patients with low vision.</article-title>
            <source>J Glaucoma</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>396</fpage>
            <page-range>396-400</page-range>
            <pub-id pub-id-type="pmid">11711837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somoza-Cano</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Abuyakoub</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jaber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Al Armashi</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Nonpsychotic Hallucinations and Impaired Vision: The Charles Bonnet Syndrome.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>e16801</fpage>
            <pub-id pub-id-type="pmid">34513407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Shahid</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thurlby</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease.</article-title>
            <source>Ophthalmic Epidemiol</source>
            <year>2008</year>
            <season>May-Jun</season>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-8</page-range>
            <pub-id pub-id-type="pmid">18569816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Vahgei</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Charles Bonnet syndrome in children.</article-title>
            <source>J AAPOS</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>310</fpage>
            <page-range>310-3</page-range>
            <pub-id pub-id-type="pmid">10646756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaphiades</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Celesia</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Brigell</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways.</article-title>
            <source>Neurology</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>408</fpage>
            <page-range>408-17</page-range>
            <pub-id pub-id-type="pmid">8757013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adachi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Onuma</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome.</article-title>
            <source>Psychiatry Clin Neurosci</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-62</page-range>
            <pub-id pub-id-type="pmid">10803809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de Haan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thoemke</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Birklein</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dieterich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karnath</surname>
                <given-names>HO</given-names>
              </name>
            </person-group>
            <article-title>Anatomical correlate of positive spontaneous visual phenomena: a voxelwise lesion study.</article-title>
            <source>Neurology</source>
            <year>2010</year>
            <month>Jan</month>
            <day>19</day>
            <volume>74</volume>
            <issue>3</issue>
            <fpage>218</fpage>
            <page-range>218-22</page-range>
            <pub-id pub-id-type="pmid">20083797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cogan</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations as release phenomena.</article-title>
            <source>Albrecht Von Graefes Arch Klin Exp Ophthalmol</source>
            <year>1973</year>
            <month>Aug</month>
            <day>23</day>
            <volume>188</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-50</page-range>
            <pub-id pub-id-type="pmid">4543235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burke</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The neural basis of Charles Bonnet hallucinations: a hypothesis.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>73</volume>
            <issue>5</issue>
            <fpage>535</fpage>
            <page-range>535-41</page-range>
            <pub-id pub-id-type="pmid">12397147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berrios</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Brook</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly.</article-title>
            <source>Age Ageing</source>
            <year>1982</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-23</page-range>
            <pub-id pub-id-type="pmid">7041567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holroyd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rabins</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Finkelstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Chase</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Wisniewski</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations in patients with macular degeneration.</article-title>
            <source>Am J Psychiatry</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>149</volume>
            <issue>12</issue>
            <fpage>1701</fpage>
            <page-range>1701-6</page-range>
            <pub-id pub-id-type="pmid">1443247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freiman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Surges</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vougioukas</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Hubbe</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Talazko</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zentner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Honegger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schulze-Bonhage</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Complex visual hallucinations (Charles Bonnet syndrome) in visual field defects following cerebral surgery. Report of four cases.</article-title>
            <source>J Neurosurg</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>101</volume>
            <issue>5</issue>
            <fpage>846</fpage>
            <page-range>846-53</page-range>
            <pub-id pub-id-type="pmid">15540925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flint</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Loh</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Brust</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Vivid visual hallucinations from occipital lobe infarction.</article-title>
            <source>Neurology</source>
            <year>2005</year>
            <month>Sep</month>
            <day>13</day>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>756</fpage>
            <pub-id pub-id-type="pmid">16157913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lance</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Simple formed hallucinations confined to the area of a specific visual field defect.</article-title>
            <source>Brain</source>
            <year>1976</year>
            <month>Dec</month>
            <volume>99</volume>
            <issue>4</issue>
            <fpage>719</fpage>
            <page-range>719-34</page-range>
            <pub-id pub-id-type="pmid">828866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lang</surname>
                <given-names>UE</given-names>
              </name>
              <name>
                <surname>Stogowski</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schulze</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Domula</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gallinat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tugtekin</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Felber</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.</article-title>
            <source>J Psychopharmacol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>553</fpage>
            <page-range>553-5</page-range>
            <pub-id pub-id-type="pmid">17446204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alao</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Hanrahan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Charles Bonnet syndrome: visual hallucination and multiple sclerosis.</article-title>
            <source>Int J Psychiatry Med</source>
            <year>2003</year>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-9</page-range>
            <pub-id pub-id-type="pmid">12968834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lepore</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways.</article-title>
            <source>Neurology</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3 Pt 1</issue>
            <fpage>444</fpage>
            <page-range>444-7</page-range>
            <pub-id pub-id-type="pmid">2314586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>K&#x000f6;lmel</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Complex visual hallucinations in the hemianopic field.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-38</page-range>
            <pub-id pub-id-type="pmid">3973619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higdon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Twilla</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sands</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Moxifloxacin-Induced Visual Hallucinations: A Case Report and Review of the Literature.</article-title>
            <source>J Pharm Pract</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-377</page-range>
            <pub-id pub-id-type="pmid">27000139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Essali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Psychosis as an adverse effect of antibiotics.</article-title>
            <source>Brain Behav Immun Health</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>9</volume>
            <fpage>100148</fpage>
            <pub-id pub-id-type="pmid">34589893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Padilla Peinado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Esteban Fern&#x000e1;ndez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez &#x000c1;lvarez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Villa Albuguer</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations related to use of ertapenem.</article-title>
            <source>Neurologia</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>8</issue>
            <fpage>520</fpage>
            <page-range>520-1</page-range>
            <pub-id pub-id-type="pmid">24684890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stults</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations related to angiotensin-converting enzyme inhibitor use: case reports and review.</article-title>
            <source>J Clin Hypertens (Greenwich)</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>230</fpage>
            <page-range>230-3</page-range>
            <pub-id pub-id-type="pmid">23551721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldner</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Metoprolol-induced visual hallucinations: a case series.</article-title>
            <source>J Med Case Rep</source>
            <year>2012</year>
            <month>Feb</month>
            <day>15</day>
            <volume>6</volume>
            <fpage>65</fpage>
            <pub-id pub-id-type="pmid">22336000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shufman</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Witztum</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vass</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Ephedrine psychosis].</article-title>
            <source>Harefuah</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>127</volume>
            <issue>5-6</issue>
            <fpage>166</fpage>
            <page-range>166-8, 215</page-range>
            <pub-id pub-id-type="pmid">7995586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freund</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Banning</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Synthetic cannabinoids: A review of the clinical implications of a new drug of choice.</article-title>
            <source>JAAPA</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>11</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">29064946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Issa</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Yussuf</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Charles bonnet syndrome, management with simple behavioral technique.</article-title>
            <source>J Neurosci Rural Pract</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-5</page-range>
            <pub-id pub-id-type="pmid">23546356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siatkowski</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Zimmer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>The Charles Bonnet syndrome. Visual perceptive dysfunction in sensory deprivation.</article-title>
            <source>J Clin Neuroophthalmol</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>215</fpage>
            <page-range>215-8</page-range>
            <pub-id pub-id-type="pmid">2144541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holroyd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rabins</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>A three-year follow-up study of visual hallucinations in patients with macular degeneration.</article-title>
            <source>J Nerv Ment Dis</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>184</volume>
            <issue>3</issue>
            <fpage>188</fpage>
            <page-range>188-9</page-range>
            <pub-id pub-id-type="pmid">8600223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ukai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of typical Charles Bonnet syndrome with donepezil.</article-title>
            <source>Int Clin Psychopharmacol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>355</fpage>
            <page-range>355-7</page-range>
            <pub-id pub-id-type="pmid">15486523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r47">
          <label>47</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Norelli</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krepps</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <chapter-title>Relaxation Techniques</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">30020610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Babu</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kanaujia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Paliwal</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Vivid Visual Hallucinations in Visually Impaired: Charles Bonnet Syndrome - An Analog to "Phantom-Limb Phenomenon".</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2020</year>
            <season>Sep-Oct</season>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>734</fpage>
            <page-range>734-735</page-range>
            <pub-id pub-id-type="pmid">33623292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livingston</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huntley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sommerlad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ames</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ballard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brayne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cohen-Mansfield</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Costafreda</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gitlin</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kales</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kivim&#x000e4;ki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Ogunniyi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orgeta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rockwood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Samus</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Selb&#x000e6;k</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Teri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mukadam</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Aug</month>
            <day>08</day>
            <volume>396</volume>
            <issue>10248</issue>
            <fpage>413</fpage>
            <page-range>413-446</page-range>
            <pub-id pub-id-type="pmid">32738937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Visual hallucinations and cataracts.</article-title>
            <source>Ophthalmic Surg</source>
            <year>1980</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-8</page-range>
            <pub-id pub-id-type="pmid">7366949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lapid</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Leavitt</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Boeve</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>Clinical phenomenology and mortality in Charles Bonnet syndrome.</article-title>
            <source>J Geriatr Psychiatry Neurol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-9</page-range>
            <pub-id pub-id-type="pmid">23385362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaudhury</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hallucinations: Etiology and clinical implications.</article-title>
            <source>Ind Psychiatry J</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-26</page-range>
            <pub-id pub-id-type="pmid">21180490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patino</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Inclusion and exclusion criteria in research studies: definitions and why they matter.</article-title>
            <source>J Bras Pneumol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>84</fpage>
            <pub-id pub-id-type="pmid">29791550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142989.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaudhury</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hallucinations: Clinical aspects and management.</article-title>
            <source>Ind Psychiatry J</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-12</page-range>
            <pub-id pub-id-type="pmid">21694785</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
